Blockchain Registration Transaction Record

Sino Biological Unveils ProPure™: Ultra-Pure, Endotoxin-Free Proteins

Sino Biological launches ProPure™, a line of ultra-pure, endotoxin-free recombinant proteins, setting new standards for research and therapeutic development.

The introduction of ProPure™ by Sino Biological represents a significant advancement in the field of bioprocessing and life sciences research. With its ultra-pure, endotoxin-free recombinant proteins, researchers and biomanufacturers can now access products that meet the highest standards of quality and consistency. This development is crucial for sensitive applications such as vaccine development and cell and gene therapy, where even minimal endotoxin contamination can affect outcomes. By offering both standard and customized protein solutions, Sino Biological is empowering the scientific community to push the boundaries of research and therapeutic development, potentially accelerating the discovery of new treatments and vaccines.